Banner

PDT + triamcinolone shows promise as treatment for non-subfoveal CNV

Article

Short-term results from a small study suggest combined verteporfin (Visudyne,Novartis) photodynamic therapy (PDT) with intravitreal triamcinolone meritsadditional investigation for the treatment of non-subfoveal CNV, said RichardF. Spaide, MD.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.